N@N

Ozempic and Wegovy are no longer in shortage, FDA says

The U.S. Food and Drug Administration (FDA) has announced that the supply issues affecting Ozempic and Wegovy, popular medications for managing type 2 diabetes and aiding weight loss, have been resolved. Previously, these drugs faced shortages due to overwhelming demand, manufacturing delays, and supply chain disruptions. The FDA's statement indicates that both medications are now readily available, alleviating concerns for patients who rely on these treatments. This news comes as a relief to many, as the shortage had led to difficulties in managing diabetes and obesity, conditions that significantly impact public health. The resolution of the shortage is attributed to increased production efforts by the manufacturers, Novo Nordisk, and better distribution strategies.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/ozempic-and-wegovy-are-no-longer-in-shortage-fda-says/ar-AA1zxjfX ]